LYSX.DE vs. AMED.DE
LYSX.DE (Amundi EURO STOXX 50 II UCITS ETF Acc) and AMED.DE (Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C)) are both Europe Equities funds from Amundi - LYSX.DE tracks the EURO STOXX® 50 while AMED.DE tracks the MSCI EMU ESG Leaders Select 5% Issuer Capped. Both are passively managed. Over the past 10 years, LYSX.DE returned 10.40%/yr vs 9.75%/yr for AMED.DE. Their correlation of 0.94 suggests significant overlap in exposure. LYSX.DE charges 0.20%/yr vs 0.25%/yr for AMED.DE.
Performance
LYSX.DE vs. AMED.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LYSX.DE achieves a 7.10% return, which is significantly lower than AMED.DE's 16.87% return. Over the past 10 years, LYSX.DE has outperformed AMED.DE with an annualized return of 10.40%, while AMED.DE has yielded a comparatively lower 9.75% annualized return.
LYSX.DE
- 1D
- 0.77%
- 1M
- 1.91%
- YTD
- 7.10%
- 6M
- 8.53%
- 1Y
- 15.65%
- 3Y*
- 15.56%
- 5Y*
- 11.43%
- 10Y*
- 10.40%
AMED.DE
- 1D
- 0.51%
- 1M
- 5.71%
- YTD
- 16.87%
- 6M
- 18.51%
- 1Y
- 26.18%
- 3Y*
- 16.11%
- 5Y*
- 10.41%
- 10Y*
- 9.75%
LYSX.DE vs. AMED.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LYSX.DE Amundi EURO STOXX 50 II UCITS ETF Acc | 7.10% | 22.03% | 11.00% | 22.54% | -8.86% | 23.39% | -2.89% | 29.99% | -12.14% | 9.97% |
AMED.DE Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C) | 16.87% | 20.15% | 5.95% | 16.68% | -10.71% | 20.90% | -1.35% | 27.22% | -12.98% | 11.86% |
Correlation
The correlation between LYSX.DE and AMED.DE is 0.94, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.94 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.95 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.97 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.97 |
Correlation (All Time) Calculated using the full available price history since Feb 25, 2010 | 0.94 |
The correlation between LYSX.DE and AMED.DE has been stable across timeframes, ranging from 0.94 to 0.97 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LYSX.DE vs. AMED.DE — Risk / Return Rank
LYSX.DE
AMED.DE
LYSX.DE vs. AMED.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi EURO STOXX 50 II UCITS ETF Acc (LYSX.DE) and Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C) (AMED.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LYSX.DE | AMED.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.75 | ||
| Sortino ratioReturn per unit of downside risk | -1.03 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.33 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.44 | 2.49 | -1.05 |
| Martin ratioReturn relative to average drawdown | 4.85 | 9.40 | -4.55 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LYSX.DE | AMED.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.99 | 1.74 | -0.75 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.65 | 0.65 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.57 | 0.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.33 | 0.47 | -0.14 |
Drawdowns
LYSX.DE vs. AMED.DE - Drawdown Comparison
The maximum LYSX.DE drawdown since its inception was -57.63%, which is greater than AMED.DE's maximum drawdown of -38.35%. Use the drawdown chart below to compare losses from any high point for LYSX.DE and AMED.DE.
Loading charts...
Drawdown Indicators
| LYSX.DE | AMED.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -57.63% | -38.35% | -19.28% |
Max Drawdown (1Y)Largest decline over 1 year | -10.87% | -10.56% | -0.31% |
Max Drawdown (3Y)Largest decline over 3 years | -16.49% | -14.07% | -2.42% |
Max Drawdown (5Y)Largest decline over 5 years | -23.32% | -24.06% | +0.74% |
Max Drawdown (10Y)Largest decline over 10 years | -38.38% | -38.35% | -0.03% |
Current DrawdownCurrent decline from peak | -0.53% | -0.17% | -0.36% |
Average DrawdownAverage peak-to-trough decline | -13.15% | -6.69% | -6.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.24% | 2.81% | +0.43% |
Volatility
LYSX.DE vs. AMED.DE - Volatility Comparison
The current volatility for Amundi EURO STOXX 50 II UCITS ETF Acc (LYSX.DE) is 4.96%, while Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C) (AMED.DE) has a volatility of 5.61%. This indicates that LYSX.DE experiences smaller price fluctuations and is considered to be less risky than AMED.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LYSX.DE | AMED.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.96% | 5.61% | -0.65% |
Volatility (6M)Calculated over the trailing 6-month period | 12.92% | 12.64% | +0.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.90% | 15.19% | +0.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.47% | 15.87% | +1.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.22% | 17.00% | +1.22% |
LYSX.DE vs. AMED.DE - Expense Ratio Comparison
LYSX.DE has a 0.20% expense ratio, which is lower than AMED.DE's 0.25% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
LYSX.DE vs. AMED.DE - Dividend Comparison
Neither LYSX.DE nor AMED.DE has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMED.DE Amundi MSCI EMU ESG Leaders Select UCITS ETF DR EUR (C) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LYSX.DE Amundi EURO STOXX 50 II UCITS ETF Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.19% | 3.26% | 3.89% | 3.19% | 3.71% | 3.85% |
Frequently Asked Questions
With a correlation of 0.94, LYSX.DE and AMED.DE move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
On fees, LYSX.DE is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LYSX.DE is cheaper with a 0.20% expense ratio, compared with 0.25% for AMED.DE.
LYSX.DE tracks EURO STOXX® 50, while AMED.DE tracks MSCI EMU ESG Leaders Select 5% Issuer Capped. Their fees differ too: 0.20% for LYSX.DE and 0.25% for AMED.DE.
Find the right allocation for LYSX.DE and AMED.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer